Literature DB >> 32046555

Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients.

Melissa Bersanelli1,2, Stefania Scala3, Paola Affanni2, Licia Veronesi2, Maria Eugenia Colucci2, Giuseppe Luigi Banna4, Alessio Cortellini5,6, Francesco Liotta7.   

Abstract

Entities:  

Keywords:  INVIDIa study; cancer patients; flu vaccine; immunological response; influenza vaccination; influenza virus

Mesh：

Substances：

Year:  2020        PMID： 32046555     DOI： 10.2217/imt-2019-0200

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  16 in total

Review 1.  Home-deliverable antitumoral treatments in the age of COVID-19: the Portsmouth experience and a narrative review.

Authors:  Hiba Mechahougui; Harliana Yusof; Nathalie Baudoux; Shyamika Acharige; Alex Friedlaender
Journal:  Mediastinum       Date:  2022-06-25

Review 2.  Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?

Authors:  Mikhail Kiselevskiy; Irina Shubina; Irina Chikileva; Suria Sitdikova; Igor Samoylenko; Natalia Anisimova; Kirill Kirgizov; Amina Suleimanova; Tatyana Gorbunova; Svetlana Varfolomeeva
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-26

3.  Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population.

Authors:  Javier Garde-Noguera; M Leonor Fernández-Murga; Vicent Giner-Bosch; Victoria Dominguez-Márquez; José García Sánchez; Juan José Soler-Cataluña; Franscica López Chuliá; Beatriz Honrubia; Nuria Piera; Antonio Llombart-Cussac
Journal:  Cancers (Basel)       Date:  2020-11-25       Impact factor: 6.639

4.  SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry.

Authors:  Rose K C Moritz; Ralf Gutzmer; Lisa Zimmer; Friedegund Meier; Misbah S Ahmed; Sabine Sell; Max Schlaak; Florian Kapp; Michael M Sachse; Sebastian Haferkamp; Julia Welzel; Katharina C Kähler; Michael Weichenthal
Journal:  Eur J Cancer       Date:  2020-11-28       Impact factor: 9.162

5.  The identity of public health in COVID-19 times.

Authors:  Anna Odone; Marco Vitale; Carlo Signorelli
Journal:  Acta Biomed       Date:  2020-07-20

6.  Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.

Authors:  Adonis Sfera; Carolina Osorio; Nyla Jafri; Eddie Lee Diaz; Jose E Campo Maldonado
Journal:  Front Immunol       Date:  2020-06-19       Impact factor: 7.561

7.  Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy.

Authors:  Melissa Bersanelli; Teresa Zielli; Fabiana Perrone; Chiara Casartelli; Fabiana Pratticò; Elena Rapacchi; Roberta Camisa; Michele Tognetto; Alberto Clemente; Diana Giannarelli; Sara Elena Rebuzzi; Alessandro Leonetti; Paola Bordi; Marcello Tiseo; Sebastiano Buti
Journal:  Immunotherapy       Date:  2020-09-15       Impact factor: 4.196

8.  Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.

Authors:  Melissa Bersanelli
Journal:  Immunotherapy       Date:  2020-03-26       Impact factor: 4.196

9.  A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab.

Authors:  Lucia Bonomi; Laura Ghilardi; Ermenegildo Arnoldi; Carlo Alberto Tondini; Anna Cecilia Bettini
Journal:  J Thorac Oncol       Date:  2020-03-31       Impact factor: 15.609

10.  Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2.

Authors:  Brendan O'Kelly; Padraig McGettrick; Daniel Angelov; Michael Fay; Tara McGinty; Aoife G Cotter; Gerard Sheehan; John S Lambert
Journal:  Br J Haematol       Date:  2020-05-07       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.